123 related articles for article (PubMed ID: 37873736)
1. The deubiquitinase USP10 mediates crosstalk between the LKB1/AMPK axis and Wnt/β-catenin signaling in cancer.
Wang Y; Liu J; Zheng S; Cao L; Li Y; Sheng R
FEBS Lett; 2023 Dec; 597(24):3061-3071. PubMed ID: 37873736
[TBL] [Abstract][Full Text] [Related]
2. USP10 strikes down β-catenin by dual-wielding deubiquitinase activity and phase separation potential.
Wang Y; Mao A; Liu J; Li P; Zheng S; Tong T; Li Z; Zhang H; Ma L; Lin J; Pang Z; Han Q; Qi F; Zhang X; Chen M; He X; Zhang X; Fei T; Liu BF; Gao D; Cao L; Wang Q; Li Y; Sheng R
Cell Chem Biol; 2023 Nov; 30(11):1436-1452.e10. PubMed ID: 37611590
[TBL] [Abstract][Full Text] [Related]
3. Deubiquitination and Activation of AMPK by USP10.
Deng M; Yang X; Qin B; Liu T; Zhang H; Guo W; Lee SB; Kim JJ; Yuan J; Pei H; Wang L; Lou Z
Mol Cell; 2016 Feb; 61(4):614-624. PubMed ID: 26876938
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of β-catenin controls both apoptotic and autophagic cell death through LKB1/AMPK signaling in head and neck squamous cell carcinoma cell lines.
Chang HW; Lee YS; Nam HY; Han MW; Kim HJ; Moon SY; Jeon H; Park JJ; Carey TE; Chang SE; Kim SW; Kim SY
Cell Signal; 2013 Apr; 25(4):839-47. PubMed ID: 23280187
[TBL] [Abstract][Full Text] [Related]
5. BAP1 regulates AMPK-mTOR signalling pathway through deubiquitinating and stabilizing tumour-suppressor LKB1.
Yang C; Ding H; Yang Y; Yang L; Yang Y; Fang M; Ren J; Hu R; Wang C; Geng W
Biochem Biophys Res Commun; 2020 Sep; 529(4):1025-1032. PubMed ID: 32819560
[TBL] [Abstract][Full Text] [Related]
6. Utilization of liquid chromatography mass spectrometry analyses to identify LKB1-APC interaction in modulating Wnt/β-catenin pathway of lung cancer cells.
Jian SF; Hsiao CC; Chen SY; Weng CC; Kuo TL; Wu DC; Hung WC; Cheng KH
Mol Cancer Res; 2014 Apr; 12(4):622-35. PubMed ID: 24448687
[TBL] [Abstract][Full Text] [Related]
7. Effect of β-catenin silencing in overcoming radioresistance of head and neck cancer cells by antagonizing the effects of AMPK on Ku70/Ku80.
Chang HW; Nam HY; Kim HJ; Moon SY; Kim MR; Lee M; Kim GC; Kim SW; Kim SY
Head Neck; 2016 Apr; 38 Suppl 1():E1909-17. PubMed ID: 26713771
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of β-Catenin Activity Abolishes LKB1 Loss-Driven Pancreatic Cystadenoma in Mice.
Hsieh MJ; Weng CC; Lin YC; Wu CC; Chen LT; Cheng KH
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33924999
[TBL] [Abstract][Full Text] [Related]
9. The tumor suppressor LKB1 antagonizes WNT signaling pathway through modulating GSK3β activity in cell growth of esophageal carcinoma.
Liu K; Luo Y; Tian H; Yu KZ; He JX; Shen WY
Tumour Biol; 2014 Feb; 35(2):995-1002. PubMed ID: 24022664
[TBL] [Abstract][Full Text] [Related]
10. USP44 suppresses proliferation and enhances apoptosis in colorectal cancer cells by inactivating the Wnt/β-catenin pathway via Axin1 deubiquitination.
Huang T; Zhang Q; Ren W; Yan B; Yi L; Tang T; Lin H; Zhang Y
Cell Biol Int; 2020 Aug; 44(8):1651-1659. PubMed ID: 32285989
[TBL] [Abstract][Full Text] [Related]
11. Wnt signaling may be activated in a subset of Peutz-Jeghers syndrome polyps closely correlating to LKB1 expression.
Ma Y; Zhang G; Fu X; Xia O; Zhan C; Li L; Wang Z; Wu B
Oncol Rep; 2010 Jun; 23(6):1569-76. PubMed ID: 20428811
[TBL] [Abstract][Full Text] [Related]
12. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
[TBL] [Abstract][Full Text] [Related]
13. LKB1 inhibits the proliferation of gastric cancer cells by suppressing the nuclear translocation of Yap and β-catenin.
Ma LG; Bian SB; Cui JX; Xi HQ; Zhang KC; Qin HZ; Zhu XM; Chen L
Int J Mol Med; 2016 Apr; 37(4):1039-48. PubMed ID: 26936013
[TBL] [Abstract][Full Text] [Related]
14. Underexpression of LKB1 tumor suppressor is associated with enhanced Wnt signaling and malignant characteristics of human intrahepatic cholangiocarcinoma.
Wang J; Zhang K; Wang J; Wu X; Liu X; Li B; Zhu Y; Yu Y; Cheng Q; Hu Z; Guo C; Hu S; Mu B; Tsai CH; Li J; Smith L; Yang L; Liu Q; Chu P; Chang V; Zhang B; Wu M; Jiang X; Yen Y
Oncotarget; 2015 Aug; 6(22):18905-20. PubMed ID: 26056085
[TBL] [Abstract][Full Text] [Related]
15. Wnt/β-Catenin Mediates AICAR Effect to Increase GATA3 Expression and Inhibit Adipogenesis.
Wang L; Di LJ
J Biol Chem; 2015 Aug; 290(32):19458-68. PubMed ID: 26109067
[TBL] [Abstract][Full Text] [Related]
16. AMPK activators suppress cervical cancer cell growth through inhibition of DVL3 mediated Wnt/β-catenin signaling activity.
Kwan HT; Chan DW; Cai PC; Mak CS; Yung MM; Leung TH; Wong OG; Cheung AN; Ngan HY
PLoS One; 2013; 8(1):e53597. PubMed ID: 23301094
[TBL] [Abstract][Full Text] [Related]
17. HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of β-catenin-FGF18 pathway.
Guo K; Ma Z; Zhang Y; Han L; Shao C; Feng Y; Gao F; Di S; Zhang Z; Zhang J; Tabbò F; Ekman S; Suda K; Cappuzzo F; Han J; Li X; Yan X
J Exp Clin Cancer Res; 2022 Mar; 41(1):91. PubMed ID: 35277183
[TBL] [Abstract][Full Text] [Related]
18. LKB1 signaling is activated in CTNNB1-mutated HCC and positively regulates β-catenin-dependent CTNNB1-mutated HCC.
Charawi S; Just PA; Savall M; Abitbol S; Traore M; Metzger N; Ravinger R; Cavard C; Terris B; Perret C
J Pathol; 2019 Apr; 247(4):435-443. PubMed ID: 30566242
[TBL] [Abstract][Full Text] [Related]
19. UCHL5 controls β-catenin destruction complex function through Axin1 regulation.
Han W; Koo Y; Chaieb L; Keum BR; Han JK
Sci Rep; 2022 Mar; 12(1):3687. PubMed ID: 35256667
[TBL] [Abstract][Full Text] [Related]
20. Concurrent regulation of LKB1 and CaMKK2 in the activation of AMPK in castrate-resistant prostate cancer by a well-defined polyherbal mixture with anticancer properties.
MacDonald AF; Bettaieb A; Donohoe DR; Alani DS; Han A; Zhao Y; Whelan J
BMC Complement Altern Med; 2018 Jun; 18(1):188. PubMed ID: 29914450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
